MedTrace Logo

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

NCT03673306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4732

Last updated 2024-12-13

Study results available
· View outcomes & findings →

Summary

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.

Conditions

Interventions

OTHER

Clinical outcomes

Clinical outcomes

Sponsors & Collaborators

  • Jules Bordet Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Canada
  • France
  • Georgia
  • Germany
  • India
  • Israel
  • Italy
  • Lebanon
  • Mexico
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • South Korea
  • Spain
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03673306 on ClinicalTrials.gov